Most California hospitals implementing infection control

March 17, 2012
Most california hospitals implementing infection control
Most California hospitals implement some policies to improve infection control for multidrug-resistant organisms (MDRO), primarily methicillin-resistant Staphylococcus aureus, but few policies are associated with lower MDRO rates, according to a study published in the March issue of the American Journal of Infection Control.

(HealthDay) -- Most California hospitals implement some policies to improve infection control for multidrug-resistant organisms (MDRO), primarily methicillin-resistant Staphylococcus aureus (MRSA), but few policies are associated with lower MDRO rates, according to a study published in the March issue of the American Journal of Infection Control.

Monika Pogorzelska, Ph.D., M.P.H., and associates from the Columbia University School of Nursing in New York City, analyzed 2010 survey data from 180 California hospitals to identify infection control policies, structural characteristics, and rates of MDRO.

The researchers found that 87 percent of the responding hospitals reported targeted MRSA screening on admission. Contact precautions were implemented by the majority of hospitals for patients with confirmed MDRO or difficile. Implementation of presumptive isolation/contact precautions for patients with pending screens was less frequent. Few infection control policies correlated with reduced MDRO rates. There was a significantly lower rate of MRSA infections in hospitals with a board certified infection control officer.

"Although most California hospitals are involved in activities to decrease MDRO, there is variation in specific activities utilized with the most focus placed on ," the authors write. "This study highlights the importance of certification and its significant impact on infection rates."

Explore further: Infection control certification associated with lower MRSA infection rates

More information: Abstract
Full Text (subscription or payment may be required)


Related Stories

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

Arthritis drug may help with type of hair loss

September 22, 2016

(HealthDay)—For people who suffer from a condition that causes disfiguring hair loss, a drug used for rheumatoid arthritis might regrow their hair, a new, small study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.